G. Yu. Chemeris

547 total citations
17 papers, 143 citations indexed

About

G. Yu. Chemeris is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. Yu. Chemeris has authored 17 papers receiving a total of 143 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. Yu. Chemeris's work include Neuroendocrine Tumor Research Advances (3 papers), Neuroblastoma Research and Treatments (3 papers) and HER2/EGFR in Cancer Research (3 papers). G. Yu. Chemeris is often cited by papers focused on Neuroendocrine Tumor Research Advances (3 papers), Neuroblastoma Research and Treatments (3 papers) and HER2/EGFR in Cancer Research (3 papers). G. Yu. Chemeris collaborates with scholars based in Russia, United Kingdom and Germany. G. Yu. Chemeris's co-authors include А. V. Komelkov, I. B. Zborovskaya, I. A. FAVORSKAYA, Elena M. Tchevkina, Vladimir S. Turusov, Peter Bannasch, Markus Schwarz, V. S. Turusov, Annette Rempel and Young Soo Ahn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Carcinogenesis and Cell Cycle.

In The Last Decade

G. Yu. Chemeris

14 papers receiving 137 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Yu. Chemeris Russia 8 93 45 41 33 19 17 143
Celine Chen United States 4 96 1.0× 60 1.3× 39 1.0× 24 0.7× 9 0.5× 5 187
George Sandusky United States 4 111 1.2× 21 0.5× 42 1.0× 23 0.7× 7 0.4× 6 165
Sonia Fernández‐Ruiz Spain 5 111 1.2× 28 0.6× 40 1.0× 61 1.8× 11 0.6× 6 167
Alexandra Meuter United States 4 134 1.4× 18 0.4× 79 1.9× 43 1.3× 18 0.9× 5 182
Laurence Faugeras Belgium 6 61 0.7× 22 0.5× 39 1.0× 45 1.4× 18 0.9× 9 128
Anaïs Boulai France 5 69 0.7× 25 0.6× 69 1.7× 64 1.9× 17 0.9× 6 167
Weihua Zhu China 6 122 1.3× 41 0.9× 54 1.3× 120 3.6× 19 1.0× 14 211

Countries citing papers authored by G. Yu. Chemeris

Since Specialization
Citations

This map shows the geographic impact of G. Yu. Chemeris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Yu. Chemeris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Yu. Chemeris more than expected).

Fields of papers citing papers by G. Yu. Chemeris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Yu. Chemeris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Yu. Chemeris. The network helps show where G. Yu. Chemeris may publish in the future.

Co-authorship network of co-authors of G. Yu. Chemeris

This figure shows the co-authorship network connecting the top 25 collaborators of G. Yu. Chemeris. A scholar is included among the top collaborators of G. Yu. Chemeris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Yu. Chemeris. G. Yu. Chemeris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chemeris, G. Yu., et al.. (2022). Treatment tactics of new NET G3 subgroup in first line of therapy. Medical alphabet. 20–24.
2.
Chemeris, G. Yu., et al.. (2020). Protein CRABP1 as one of the possible prognosis factors in children with high-risk neuroblastoma. Russian Journal of Pediatric Hematology and Oncology. 6(4). 48–54. 1 indexed citations
3.
Chemeris, G. Yu., et al.. (2019). Immunohistochemical evaluation of vimentin aberrant expression in lung carcinoid tumors. SHILAP Revista de lepidopterología. 5(4). 104–109.
4.
5.
Логинов, В. И., et al.. (2018). Synchronous endometrioid tumors of the uterus and the ovaries. Complicacy of interpretation. Russian Journal of Human Reproduction. 24(4). 66–66. 2 indexed citations
6.
FAVORSKAYA, I. A., et al.. (2014). Expression and clinical significance of CRABP1 and CRABP2 in non-small cell lung cancer. Tumor Biology. 35(10). 10295–10300. 32 indexed citations
7.
FAVORSKAYA, I. A., G. Yu. Chemeris, А. V. Komelkov, et al.. (2014). CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors. Cell Cycle. 13(10). 1530–1539. 28 indexed citations
8.
Chemeris, G. Yu., et al.. (2010). Squamous Cell Carcinoma of the Esophagus: Evaluation of the Status of Epidermal Growth Factor Receptors (EGFR and HER-2) by Immunohistochemistry and in Situ Hybridization. Bulletin of Experimental Biology and Medicine. 149(5). 615–620. 11 indexed citations
9.
Chemeris, G. Yu., et al.. (2009). Clinical Significance of Hyperexpression of Epidermal Growth Factor Receptors (EGFR and HER-2) in Esophageal Squamous Cell Carcinoma. Bulletin of Experimental Biology and Medicine. 148(2). 241–245. 12 indexed citations
10.
Кушлинский, Н. Е., et al.. (2007). Soluble fragment of Her2/neu receptor in the serum of patients with breast cancer with different levels of this protein expression in the tumor. Bulletin of Experimental Biology and Medicine. 143(4). 449–451. 3 indexed citations
11.
Chemeris, G. Yu., et al.. (1995). Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 426(6). 563–9. 21 indexed citations
12.
Ahn, Young Soo, G. Yu. Chemeris, Vladimir S. Turusov, & Peter Bannasch. (1994). Enzymic Pattern of Preneoplastic and Neoplastic Lesions Induced in the Kidney of CBA Mice by 1,2-Dimethylhydrazine. Toxicologic Pathology. 22(4). 415–422. 11 indexed citations
13.
Kolyada, Alexey Y., et al.. (1993). Regulation of CYP1A induction in hepatoma 27 depending on the site of transplantation. Xenobiotica. 23(6). 703–708. 3 indexed citations
14.
Turusov, Vladimir S. & G. Yu. Chemeris. (1992). Renal Cell Tumors Induced in CBA Male Mice by 1,2-Dimethylhydrazine. Toxicologic Pathology. 20(4). 570–575. 10 indexed citations
15.
16.
Turusov, V. S. & G. Yu. Chemeris. (1983). Effect of testosterone propionate on induction of renal capsule angiosarcomas by 1,2-dimethylhydrazine in castrated mice. Bulletin of Experimental Biology and Medicine. 95(2). 250–252. 1 indexed citations
17.
Turusov, V. S. & G. Yu. Chemeris. (1976). Modification of toxic effects of DMBA by DDT and DDE. Chemico-Biological Interactions. 15(3). 295–298. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celine Chen Breakdown of academic impact, for papers by George Sandusky Breakdown of academic impact, for papers by Sonia Fernández‐Ruiz Breakdown of academic impact, for papers by Alexandra Meuter Breakdown of academic impact, for papers by Laurence Faugeras Breakdown of academic impact, for papers by Anaïs Boulai Breakdown of academic impact, for papers by Weihua Zhu
Rankless by CCL
2026